• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: June 19, 2025

Key Takeaways

  • UCSD's Clean Slate Program enhances medical education and community health through hands-on tattoo removal experience, supporting social justice efforts.
  • Social media significantly impacts skin health attitudes and behaviors, as evidenced by a systematic review of related research.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Ink to Impact: A Laser-Focused Mission in Justice and Dermatology

UCSD's Clean Slate Program empowers medical students through hands-on experience in tattoo removal, enhancing community health and social justice initiatives.

Social Media Significantly Influences Attitudes, Behaviors Toward Skin Health

Researchers conducted a systematic review to summarize research that has addressed social media’s impact on skin health promotion activities.

VALIANT Survey Shows High Rates of Depression in Patients with Vitiligo

The VALIANT survey uncovers alarming depression rates in vitiligo patients, highlighting the urgent need for improved mental health screenings and interventions.

Upadacitinib Induces Long-Term Remission in Refractory Bullous Pemphigoid: A Case Report

Upadacitinib’s targeted inhibition of JAK1 offers a novel strategy for managing bullous pemphigoid, and in rare, treatment-resistant cases, may induce sustained remission following immune modulation.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.